{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:19:04Z","timestamp":1790216344343,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T00:00:00Z","timestamp":1348185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Respir Care Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s13665-012-0028-7","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T02:52:37Z","timestamp":1348109557000},"page":"224-232","source":"Crossref","is-referenced-by-count":108,"title":["Connective tissue disease-associated interstitial lung disease: a review"],"prefix":"10.1007","volume":"1","author":[{"given":"Markus","family":"Gutsche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn D.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Swigris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,21]]},"reference":[{"issue":"2","key":"28_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.10-0194","volume":"138","author":"A Fischer","year":"2010","unstructured":"\u2022\u2022 Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest. 2010;138(2):251\u20136. A synopsis and discussion of \u201clung-dominant connective tissue diseases\u201d, \u201cautoimmune-featured ILD\u201d and \u201cundifferentiated connective tissue diseases\u201d including a proposal for criteria to more accurately capture the group of \u201clung-dominant CTDs\u201d.","journal-title":"Chest"},{"issue":"5","key":"28_CR2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.10-2662","volume":"140","author":"R Vij","year":"2011","unstructured":"Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011;140(5):1292\u20139.","journal-title":"Chest"},{"issue":"5","key":"28_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000196457","volume":"62","author":"Y Homma","year":"1995","unstructured":"Homma Y, Ohtsuka Y, Tanimura K, Kusaka H, Munakata M, Kawakami Y, Ogasawara H. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration. 1995;62(5):248.","journal-title":"Respiration"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2007-985610","volume":"28","author":"AU Wells","year":"2007","unstructured":"\u2022\u2022 Wells AU. Pulmonary function tests in connective tissue disease. Semin Respir Crit Care Med. 2007;28:379\u201388. Excellent summary on pulmonary function test patterns observed in CTD-ILD.","journal-title":"Semin Respir Crit Care Med"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","volume":"127","author":"H Lee","year":"2005","unstructured":"Lee H, Kim DS, Yoo B, Seo JB, Rho J, Colby TV, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127:2019\u201327.","journal-title":"Chest"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","volume":"232","author":"N Tanaka","year":"2004","unstructured":"\u2022 Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232:81\u201391. Description of characteristic HRCT-patterns in patients with RA-related ILD.","journal-title":"Radiology"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1378\/chest.08-2572","volume":"136","author":"JW Song","year":"2009","unstructured":"Song JW, Do K, Kim M, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest. 2009;136:23\u201330.","journal-title":"Chest"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","volume":"175","author":"JH Park","year":"2007","unstructured":"Park JH, Kim DS, Park I, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175:705\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35:1322\u20138.","journal-title":"Eur Respir J"},{"key":"28_CR10","unstructured":"\u2022\u2022 King TE Jr, Kim EJ, Kinder BW. Connective tissue diseases. In: King TE, Schwartz M, editors. Interstitial lung disease. 5th ed; 2011. Detailed review of connective tissue disease \u2013 related interstitial lung diseases from standard reference textbook for the interstitial lung diseases."},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1148\/radiographics.22.suppl_1.g02oc04s151","volume":"22","author":"EA Kim","year":"2002","unstructured":"Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics. 2002;22:S151\u201365.","journal-title":"Radiographics"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/RCT.0b013e318181d551","volume":"33","author":"JH Hwang","year":"2009","unstructured":"\u2022\u2022 Hwang JH, Misumi S, Sahin H, et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J Comput Assist Tomogr. 2009;33:410\u20135. Comprehensive reviews of radiologic and histopathologic features in CTD-ILD.","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"28_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/RTI.0b013e3181c1acec","volume":"24","author":"DA Lynch","year":"2009","unstructured":"\u2022\u2022 Lynch DA. Lung disease related to collagen vascular disease. J Thoracic Imaging. 2009;24(4):299\u2013309. Excellent overview of radiologic, serologic and histopathologic patterns of lung injury from CTD.","journal-title":"J Thoracic Imaging"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006;354:2655\u201366.","journal-title":"N Engl J Med"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NSL, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum. 2006;54:3962\u201370.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"28_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MAJ.0b013e31818d094b","volume":"337","author":"LA Saketkoo","year":"2009","unstructured":"Saketkoo LA, Espinoza LR. Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects. Am J Med Sci. 2009 May;337(5):329\u201335.","journal-title":"Am J Med Sci"},{"key":"28_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.130.1.30","volume":"130","author":"JJ Swigris","year":"2006","unstructured":"Swigris JJ, Olson AL, Fischer A, et al. Mycophenolate mofetil is safe, well-tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest. 2006;130:30\u20136.","journal-title":"Chest"},{"issue":"2","key":"28_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1586\/ecp.12.9","volume":"5","author":"A Kobayashi","year":"2012","unstructured":"Kobayashi A, Okamoto H. Treatment of interstitial lung diseases associated with connective tissue diseases. Expert Rev Clin Pharmacol. 2012;5(2):219\u201327.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"28_CR19","first-page":"395","volume":"10","author":"RH Hyland","year":"1983","unstructured":"Hyland RH, Gordon DA, Broder I, Davies GM, Russell ML, Hutcheon MA, et al. A systematic controlled study of pulmonary abnormalities in rheumatoid arthritis. J Rheumatol. 1983;10:395\u2013405.","journal-title":"J Rheumatol"},{"key":"28_CR20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009748209098194","volume":"11","author":"AG Jurik","year":"1982","unstructured":"Jurik AG, Davidsen D, Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol. 1982;11:217\u201324.","journal-title":"Scand J Rheumatol"},{"key":"28_CR21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay E, Tarala R, Will R, Carroll G, Adler B, Cameron D, Lake FR. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997;156:528\u201335.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","volume":"56","author":"KG Saag","year":"1997","unstructured":"Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis. 1997;56:463\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"28_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rdc.2010.02.001","volume":"36","author":"KD Deane","year":"2010","unstructured":"Deane KD, Norris JM, Holers VM. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation. Rheum Dis Clin North Am. 2010;36(2):213\u201341.","journal-title":"Rheum Dis Clin North Am"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.53.7.434","volume":"53","author":"P Barrera","year":"1994","unstructured":"Barrera P, Laan RF, van Riel PL, Dekhuijzen PN, Boerbooms AM, van de Putte LB. Methotrexate-related pulmonary complications in rheumatoid arthritis. Ann Rheum Dis. 1994;53:434\u20139.","journal-title":"Ann Rheum Dis"},{"key":"28_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10165-005-0387-9","volume":"15","author":"F Sakai","year":"2005","unstructured":"Sakai F, Noma S, Kurihara Y, Yamada H, Azuma A, Kudoh S, et al. Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features. Mod Rheumatol. 2005;15:173\u20139.","journal-title":"Mod Rheumatol"},{"key":"28_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.40.2.136","volume":"40","author":"DL Scott","year":"1981","unstructured":"Scott DL, Bradby GV, Aitman TJ, Zaphiropoulos GC, Hawkins CF. Relationship of gold and penicillamine therapy to diffuse interstitial lung disease. Ann Rheum Dis. 1981;40:136\u201341.","journal-title":"Ann Rheum Dis"},{"key":"28_CR27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.02.00267402","volume":"19","author":"SD Parry","year":"2002","unstructured":"Parry SD, Barbatzas C, Peel ET, Barton JR. Sulphasalazine and lung toxicity. Eur Respir J. 2002;19:756\u201364.","journal-title":"Eur Respir J"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2009.01.002","volume":"103","author":"K Thavarajah","year":"2009","unstructured":"Thavarajah K, Wu P, Rhew EJ, Yeldandi AK, Kamp DW. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med. 2009;103:661\u20139.","journal-title":"Respir Med"},{"key":"28_CR29","unstructured":"\u2022\u2022 pneumotox.com \u2013 Foucher P, Camus P. The drug-induced lung diseases. Very useful online tool that allows searches for individual medications listing all respective drug-induced pulmonary complications described in the literature."},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-93-3-407","volume":"93","author":"T Abel","year":"1980","unstructured":"Abel T, Andrews BS, Cunningham PH, et al. Rheumatoid vasculitis: Effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Intern Med. 1980;93:407\u201313.","journal-title":"Ann Intern Med"},{"key":"28_CR31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3346\/jkms.2002.17.2.270","volume":"17","author":"HK Chang","year":"2002","unstructured":"Chang HK, Park W, Ryu DS. Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: A case report. J Korean Med Sci. 2002;17:270\u20133.","journal-title":"J Korean Med Sci"},{"key":"28_CR32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/thx.35.10.725","volume":"35","author":"DGI Scott","year":"1980","unstructured":"Scott DGI, Bacon PA. Resonse to methotrexate in fibrosing alveolitis associated with connective tissue disease. Thorax. 1980;35:725\u201331.","journal-title":"Thorax"},{"key":"28_CR33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1085-5629(98)80062-X","volume":"17","author":"VD Steen","year":"1998","unstructured":"\u2022 Steen VD. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg. 1998;17:48\u201354. A comprehensive review of the general clinical features of systemic sclerosis.","journal-title":"Semin Cutan Med Surg"},{"key":"28_CR34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","volume":"60","author":"E Hachulla","year":"2009","unstructured":"Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60:1831\u20139.","journal-title":"Arthritis Rheum"},{"key":"28_CR35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","volume":"49","author":"JD Reveille","year":"2003","unstructured":"\u2022 Reveille JD, Solomon DH. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003;49:399\u2013412. This article is part of a series on immunologic testing guidelines published by the American College of Rheumatology and HOC Committee on Immunologic Testin. For further details an introduction to this series has been published in Arthritis Care and Research, Vol 47, Nr 4, August 2002 pp 429 \u2013433.","journal-title":"Arthritis Rheum"},{"key":"28_CR36","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros D, Wells AU, Nicholson AG, Cobly TV, Polychronopoulos V, Pantelidis P, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002;165:1581\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NSL Goh","year":"2008","unstructured":"Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008;177:1248\u201354.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR38","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q","volume":"41","author":"M Haubitz","year":"1998","unstructured":"Haubitz M, Schellong S, G\u00f6bel U, Schurek HJ, Schaumann D, Koch KM, et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum. 1998;41:1835\u201344.","journal-title":"Arthritis Rheum"},{"key":"28_CR39","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","volume":"176","author":"DP Tashkin","year":"2007","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2\u00a0years in scleroderma lung disease. Am J Respir Crit Care Med. 2007;176:1026\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"28_CR41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"\u2022 Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403\u20137. Original description and diagnostic criteria for polymyositis and dermatomyositis by Bohan and Peter.","journal-title":"N Engl J Med"},{"key":"28_CR42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archderm.1975.01630140099013","volume":"111","author":"L Krain","year":"1975","unstructured":"Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol. 1975;111:241\u20135.","journal-title":"Arch Dermatol"},{"key":"28_CR43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2007-985666","volume":"28","author":"M Fathi","year":"2007","unstructured":"\u2022 Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med. 2007;28:451\u20138. A comprehensive review of polymyositis and dermatomyositis with emphasis on the pulmonary manifestation.","journal-title":"Semin Respir Crit Care Med"},{"key":"28_CR44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","volume":"11","author":"J Ikezoe","year":"1996","unstructured":"\u2022 Ikezoe J, Johkoh T, Kohno N, et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imag. 1996;11:250\u20139. A review of radiological features on chest HRCT in PM\/DM.","journal-title":"J Thorac Imag"},{"key":"28_CR45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0272-5231(05)70111-8","volume":"19","author":"MI Schwarz","year":"1998","unstructured":"Schwarz MI. The lung in polymyositis. Clin Chest Med. 1998;19:701\u201312. viii.","journal-title":"Clin Chest Med"},{"key":"28_CR46","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.rmed.2007.02.017","volume":"101","author":"J Won Huh","year":"2007","unstructured":"Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M, et al. Two distinct clinical types of interstitial lung disease associated with polymyositis\/dermatomyositis. Respir Med. 2007;101:1761\u20139.","journal-title":"Respir Med"},{"key":"28_CR47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","volume":"44","author":"D Tansey","year":"2004","unstructured":"Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44:585\u201396.","journal-title":"Histopathology"},{"key":"28_CR48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-B\u00e9jui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003;22:245\u201350.","journal-title":"Eur Respir J"},{"key":"28_CR49","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/sarh.2002.50012","volume":"32","author":"A Schnabel","year":"2003","unstructured":"Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum. 2003;32:273\u201384.","journal-title":"Semin Arthritis Rheum"},{"key":"28_CR51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996;26:459\u201367.","journal-title":"Semin Arthritis Rheum"},{"key":"28_CR52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","volume":"28","author":"I Chen","year":"2009","unstructured":"Chen I, Jan Wu Y, Lin C, Fan K, Luo S, Ho H. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol. 2009;28:639\u201346.","journal-title":"Clin Rheumatol"},{"key":"28_CR53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"M Dalakas","year":"2003","unstructured":"\u2022 Dalakas M, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971\u201382. A comprehensive review of the general clinical features of polymyositis and dermatomyositis.","journal-title":"Lancet"},{"key":"28_CR54","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0272-5231(05)70106-4","volume":"19","author":"J Evans","year":"1998","unstructured":"Evans J. Antinuclear antibody testing in systemic autoimmune disease. Clin Chest Med. 1998;19:613\u201325. vii.","journal-title":"Clin Chest Med"},{"key":"28_CR55","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1038\/jid.1993.34","volume":"100","author":"IN Targoff","year":"1993","unstructured":"Targoff IN. Humoral immunity in polymyositis\/dermatomyositis. J Invest Dermatol. 1993;100:116S\u201323.","journal-title":"J Invest Dermatol"},{"key":"28_CR56","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Ch\u00e9rin P, Dominique S, Hatron P, Hellot M, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002;47:614\u201322.","journal-title":"Arthritis Rheum"},{"key":"28_CR57","first-page":"1336","volume":"25","author":"I Marie","year":"1998","unstructured":"Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 1998;25:1336\u201343.","journal-title":"J Rheumatol"},{"key":"28_CR58","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1191\/0961203305lu2158oa","volume":"14","author":"A Selva-O\u2019Callaghan","year":"2005","unstructured":"Selva-O\u2019Callaghan A, Labrador-Horrillo M, Mu\u00f1oz-Gall X, Mart\u00ednez-Gomez X, Maj\u00f3-Masferrer J, Solans-Laque R, et al. Polymyositis\/dermatomyositis associated lung disease: analysis of a series of 81 patients. Lupus. 2005;14:534\u201342.","journal-title":"Lupus"},{"key":"28_CR59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","volume":"70","author":"A Imbert-Masseau","year":"2003","unstructured":"Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Ch\u00e9rin P. Antisynthetase syndrome. Joint Bone Spine. 2003;70:161\u20138.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"28_CR60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10067-009-1358-x","volume":"29","author":"M Ando","year":"2010","unstructured":"Ando M, Miyazaki E, Yamasue M, Sadamura Y, Ishii T, Takenaka R, Ito T, Nureki S, Kumamoto T. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol. 2010;29(4):443\u20135.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"28_CR61","first-page":"707","volume":"23","author":"S Ochi","year":"2005","unstructured":"Ochi S, Nanki T, Takada K, Suzuki F, Komano Y, Kubota T, Miyasaka N. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis\/dermatomyositis. Clin Exp Rheumatol. 2005;23(5):707\u201310.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"28_CR62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","volume":"46","author":"Y Yamasaki","year":"2007","unstructured":"Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S, Kurihara Y, Osada H, Satoh M, Ozaki S. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis. Rheumatology (Oxford). 2007;46(1):124.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"28_CR63","first-page":"1719","volume":"32","author":"H Kameda","year":"2005","unstructured":"Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol. 2005;32(9):1719.","journal-title":"J Rheumatol"},{"key":"28_CR64","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","volume":"48","author":"M Sem","year":"2009","unstructured":"Sem M, Molberg O, Lund MB, Gran JT. Rituximab treatment of the anti-synthetase syndrome: a retrospective case series. Rheumatology (Oxford). 2009;48:968\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"28_CR65","first-page":"1369","volume":"32","author":"O Lambotte","year":"2005","unstructured":"Lambotte O, Kotb R, Maigne G, Blanc F, Goujard C, Delfraissy JF. Efficacy of rituximab in refractory polymyositis. J Rheumatol. 2005;32:1369\u201370.","journal-title":"J Rheumatol"},{"issue":"3","key":"28_CR66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00408-009-9146-6","volume":"187","author":"Y Suzuki","year":"2009","unstructured":"Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis\/dermatomyositis. Lung. 2009;187(3):201.","journal-title":"Lung"},{"issue":"suppl II","key":"28_CR67","first-page":"1","volume":"11","author":"H Sj\u00f6gren","year":"1933","unstructured":"Sj\u00f6gren H. Zur Kenntnis der keratoconjunctivitis sicca. Acta Ophthalomol. 1933;11(suppl II):1.","journal-title":"Acta Ophthalomol"},{"key":"28_CR68","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"\u2022 Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American \u2013European Consensus Group. Ann Rheum Dis. 2002;61:554\u20138. Diagnostic criteria for primary and secondary Sj\u00f6gren\u2019s syndrome following revision by the European Study Group on Classification Criteria for Sj\u00f6gren\u2019s syndrome.","journal-title":"Ann Rheum Dis"},{"key":"28_CR69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005792-198207000-00004","volume":"61","author":"EL Alexander","year":"1982","unstructured":"Alexander EL, Provost TT, Stevens MB, Alexander GE. Neurologic complications of primary Sj\u00f6gren\u2019s syndrome. Medicine (Baltimore). 1982;61:247\u201357.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR70","first-page":"2253","volume":"34","author":"S Carine","year":"2007","unstructured":"Carine S, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X. Anticentromere antibodies identify patients with Sj\u00f6gren\u2019s syndrome and autoimmune overlap syndrome. J Rheumatol. 2007;34:2253\u20138.","journal-title":"J Rheumatol"},{"key":"28_CR71","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.1780230703","volume":"23","author":"M Fischbach","year":"1980","unstructured":"Fischbach M, Char D, Christensen M, et al. Immune complexes in Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 1980;23:791\u20135.","journal-title":"Arthritis Rheum"},{"key":"28_CR72","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"R Fox","year":"2005","unstructured":"\u2022 Fox R. Sj\u00f6gren\u2019s syndrome. Lancet. 2005;366:321\u201331. A comprehensive review of the general clinical features of Sj\u00f6gren\u2019s syndrome.","journal-title":"Lancet"},{"key":"28_CR73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","volume":"90","author":"B Royer","year":"1997","unstructured":"Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al. Lymphomas in patients with Sj\u00f6gren\u2019s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90:766\u201375.","journal-title":"Blood"},{"key":"28_CR74","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1378\/chest.90.3.370","volume":"90","author":"MP Papathanasiou","year":"1986","unstructured":"Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM. Reappraisal of respiratory abnormalities in primary and secondary Sj\u00f6gren\u2019s syndrome. A controlled study. Chest. 1986;90:370\u20134.","journal-title":"Chest"},{"key":"28_CR75","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87:210\u20139.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.88.2.226","volume":"88","author":"SH Constantopoulos","year":"1985","unstructured":"Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sj\u00f6gren\u2019s syndrome. A clinical, functional, and histologic study. Chest. 1985;88:226\u20139.","journal-title":"Chest"},{"key":"28_CR77","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0272-5231(05)70110-6","volume":"19","author":"HC Cain","year":"1998","unstructured":"\u2022 Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Clin Chest Med. 1998;19:687\u201399. viii. A comprehensive review of the pleuro-pulmonary manifestations of SjS.","journal-title":"Clin Chest Med"},{"key":"28_CR78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","volume":"86","author":"D Launay","year":"2007","unstructured":"Launay D, Hachulla E, Hatron P, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sj\u00f6gren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86:299\u2013315.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR79","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5694\/j.1326-5377.2006.tb00242.x","volume":"184","author":"H Chen","year":"2006","unstructured":"Chen H, Lai S, Kwang W, Liu J, Chen C, Huang D. Middle lobe syndrome as the pulmonary manifestation of primary Sj\u00f6gren\u2019s syndrome. Med J Aust. 2006;184:294\u20135.","journal-title":"Med J Aust"},{"key":"28_CR80","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/1529-0131(199910)42:10<2249::AID-ANR31>3.0.CO;2-4","volume":"42","author":"A Tavoni","year":"1999","unstructured":"Tavoni A, Vitali C, Cirigliano G, Frigelli S, Stampacchia G, Bombardieri S. Shrinking lung in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 1999;42:2249\u201350.","journal-title":"Arthritis Rheum"},{"key":"28_CR81","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","volume":"130","author":"JG Parambil","year":"2006","unstructured":"\u2022 Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sj\u00f6gren syndrome. Chest. 2006;130:1489\u201395. A comprehensive overview of interstitial lung diseases in SjS.","journal-title":"Chest"},{"key":"28_CR82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00296-002-0204-0","volume":"22","author":"I Yamadori","year":"2002","unstructured":"Yamadori I, Fujita J, Bandoh S, Tokuda M, Tanimoto Y, Kataoka M, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int. 2002;22:89\u201392.","journal-title":"Rheumatol Int"},{"issue":"Suppl 5","key":"28_CR83","first-page":"v1","volume":"63","author":"B Bradley","year":"2008","unstructured":"Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1\u201358.","journal-title":"Thorax"},{"key":"28_CR84","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-2007-985611","volume":"28","author":"A Devaraj","year":"2007","unstructured":"Devaraj A, Wells AU, Hansell DM. Computed tomographic imaging in connective tissue diseases. Semin Respir Crit Care Med. 2007;28:389\u201397.","journal-title":"Semin Respir Crit Care Med"},{"key":"28_CR85","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005382-200110000-00010","volume":"16","author":"M Koyama","year":"2001","unstructured":"Koyama M, Johkoh T, Honda O, Mihara N, Kozuka T, Tomiyama N, et al. Pulmonary involvement in primary Sj\u00f6gren\u2019s syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging. 2001;16:290\u20136.","journal-title":"J Thorac Imaging"},{"key":"28_CR86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2214\/ajr.173.1.10397102","volume":"173","author":"O Honda","year":"1999","unstructured":"\u2022 Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol. 1999;173:71\u20134. An interesting study comparing HRCT-findings of lymphocytic interstitial pneumonia and malignant lymphoma of the chest to delineate the differentiating features of these two disorders.","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"28_CR87","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/ard.49.11.947","volume":"49","author":"R Cervera","year":"1990","unstructured":"Cervera R, Khamashta MA, Hughes GR. \u201cOverlap\u201d syndromes. Ann Rheum Dis. 1990;49(11):947.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"28_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2006.03.004","volume":"6","author":"M Mosca","year":"2006","unstructured":"\u2022 Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev. 2006;6(1):1. Description of \u201cundifferentiated connective tissue diseases\u201d as a distinct disease entity.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"28_CR89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"\u2022 Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148. Original description of \u201cmixed connective tissue disease\u201d as a separate disease entity by Sharp et al.","journal-title":"Am J Med"},{"key":"28_CR90","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/keh575","volume":"44","author":"E Bodolay","year":"2005","unstructured":"Bodolay E, Szekanecz Z, D\u00e9v\u00e9nyi K, Galuska L, Cs\u00edpo I, V\u00e8gh J, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford). 2005;44:656\u201361.","journal-title":"Rheumatology (Oxford)"},{"key":"28_CR91","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-5231(05)70113-1","volume":"19","author":"UB Prakash","year":"1998","unstructured":"\u2022 Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 1998;19:733\u201346. ix. A comprehensive review of MCTD-related pulmonary complications.","journal-title":"Clin Chest Med"},{"key":"28_CR92","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00005792-198403000-00003","volume":"63","author":"WD Sullivan","year":"1984","unstructured":"Sullivan WD, Hurst DJ, Harmon CE, Esther JH, Agia GA, Maltby JD, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore). 1984;63:92\u2013107.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR93","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.22641","volume":"56","author":"EF Chakravarty","year":"2007","unstructured":"Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007;56:2092\u20134.","journal-title":"Arthritis Rheum"},{"key":"28_CR94","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF02591422","volume":"22","author":"AJ Swaak","year":"1992","unstructured":"Swaak AJ, Nossent JC, Smeenk RJ. Systemic lupus erythematosus. Int J Clin Lab Res. 1992;22:190\u20135.","journal-title":"Int J Clin Lab Res"},{"key":"28_CR95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R Cervera","year":"1993","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993;72:113\u201324.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR96","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"\u2022 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271\u20137. Revised Criteria for the diagnosis of SLE from the Subcommittee for Systemic Lupus Erythematosus Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.","journal-title":"Arthritis Rheum"},{"key":"28_CR97","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2214\/ajr.166.2.8553934","volume":"166","author":"HM Fenlon","year":"1996","unstructured":"Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol. 1996;166:301\u20137.","journal-title":"AJR Am J Roentgenol"},{"key":"28_CR98","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.berh.2009.01.002","volume":"23","author":"JM Pego-Reigosa","year":"2009","unstructured":"\u2022 Pego-Reigosa JM, Medeiros DA, Isenberg DA. Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin Rheumatol. 2009;23:469\u201380. Concise review of the pulmonary manifestations in SLE.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"28_CR99","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","volume":"78","author":"R Cervera","year":"1999","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1999;78:167\u201375.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/rheumatology\/35.3.248","volume":"35","author":"T Stoll","year":"1996","unstructured":"Stoll T, Seifert B, Isenberg DA. SLICC\/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol. 1996;35:248\u201354.","journal-title":"Br J Rheumatol"},{"key":"28_CR101","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1148\/radiology.196.3.7644652","volume":"196","author":"AA Bankier","year":"1995","unstructured":"Bankier AA, Kiener HP, Wiesmayr MN, Fleischmann D, Kontrus M, Herold CJ, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology. 1995;196:835\u201340.","journal-title":"Radiology"},{"key":"28_CR102","first-page":"507","volume":"15","author":"SM Sant","year":"1997","unstructured":"Sant SM, Doran M, Fenelon HM, Breatnach ES. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol. 1997;15:507\u201313.","journal-title":"Clin Exp Rheumatol"},{"key":"28_CR103","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-197509000-00003","volume":"54","author":"RA Matthay","year":"1975","unstructured":"Matthay RA, Schwarz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore). 1975;54:397\u2013409.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR104","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0272-5231(05)70105-2","volume":"19","author":"TV Colby","year":"1998","unstructured":"Colby TV. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med. 1998;19:587\u2013612. vii.","journal-title":"Clin Chest Med"},{"key":"28_CR105","first-page":"2254","volume":"24","author":"JK Min","year":"1997","unstructured":"Min JK, Hong YS, Park SH, Park JH, Lee SH, Lee YS, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol. 1997;24:2254\u20137.","journal-title":"J Rheumatol"},{"key":"28_CR106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.rti.0000099464.94973.51","volume":"19","author":"MS Filipek","year":"2004","unstructured":"Filipek MS, Thompson ME, Wang P, Gosselin MV, Primack LS. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging. 2004;19:200\u20133.","journal-title":"J Thorac Imaging"},{"key":"28_CR107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0049-0172(84)90009-X","volume":"14","author":"S Carette","year":"1984","unstructured":"Carette S, Macher AM, Nussbaum A, Plotz PH. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum. 1984;14:52\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"28_CR108","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005792-199705000-00005","volume":"76","author":"MR Zamora","year":"1997","unstructured":"Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76:192\u2013202.","journal-title":"Medicine (Baltimore)"},{"key":"28_CR109","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0961203309104860","volume":"18","author":"DJ Todd","year":"2009","unstructured":"Todd DJ, Costenbader KH. Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus. 2009;18:777\u201384.","journal-title":"Lupus"}],"container-title":["Current Respiratory Care Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13665-012-0028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13665-012-0028-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13665-012-0028-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:54:40Z","timestamp":1594688080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13665-012-0028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,21]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s13665-012-0028-7","relation":{},"ISSN":["2161-332X"],"issn-type":[{"value":"2161-332X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,21]]}}}